Navigation Links
Large Vein Occlusive Disease: Diagnosis and Treatment Options to be Presented at the 40th Annual VEITHsymposium in New York
Date:11/20/2013

NEW YORK, Nov. 20, 2013 /PRNewswire-iReach/ -- Large vein occlusive disease is on the rise, especially in diabetic patients.  Management of deep vein thrombosis (DVT) of the upper extremity due to thoracic outlet syndrome compressing the subclavian vein and of the lower extremity due to iliac vein stenosis remains controversial.  Media is invited to attend any and all presentations relative to large vein occlusive disease presented at the 40th Annual VEITHsymposium in New York. The session will commence on Thursday, November 21st, 1:00 P.M. to 5:00 P.M. located in Americas Hall I, 3rd Floor of the New York Hilton-Midtown (NY, NY). Kenneth Ouriel, MD, MBA, FACS, FACC will moderate the session.

    Dr. Ouriel said, "This session will be particularly interesting to the media.  We will discuss state-of-the-art diagnostic and treatment modalities for large vein occlusion in the upper and lower extremities.  Therapy for axillo/subclavian and lower extremity venous stenotic and occlusive disease continues to evolve, with accumulating data on pharmacologic, mechanical, and open surgical modalities. There is much to be learned."  Media will have an opporunity to interview presenters in the VEITHsymposium press office. 

     The recent advent of stents engineered specifically for the venous anatomy and physiology provides a timely setting to discuss the indications and early outcome of endovascular therapy for venous occlusion.  Lastly, clinicians who are highly skilled in these demanding procedures will present the indications and operative techniques for major open surgical reconstruction of the vena cava and other large veins. 

     Ouriel concluded, "In short, accumulating data on large vessel venous occlusion affords opportunities for the patient and the vascular practitioner alike.  Newly gained knowledge of the disease and the results of treatment can be applied to a larger proportion of the underserved population with venous disease; at the same time expanding the armamentarium of effective interventions available to the practicing clinician."  

     Experts will address the unmet needs and opportunities for the future, other commonly encountered venous occlusive problems and their treatment, treatment of lower extremityDVT, balloons, stents, thrombolysis, ultrasound thrombolysis, mechanical thrombectomy, and inferior vena caval issues (including endovascular and open surgical management). 

     About VEITHsymposium: Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 750 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend the VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780 or email.

Media Contact: Pauline Mayer, PTM Healthcare Marketing, Inc., 631-979-3780, ptm@ptmhcm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE VEITHsymposium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
2. Does Your Business Have the Tools to Compete in the Worlds Largest Diagnostics Markets?
3. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
4. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
5. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
6. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
7. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
8. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
9. Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
10. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
11. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells are ... characterized by self-renewal and the capacity to differentiate into ... new discovery, as the first mouse embryonic stem cells ... not until 1995 that the first culturing of embryonic ... cells were not produced until 2006 As a result ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. Cuomo ... create 1,400 jobs throughout Western New York ... with the SUNY Polytechnic Institute, includes a major expansion ... in Buffalo , as well as ... facility in Dunkirk . The combined ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 ... ... today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced ... will recruit top students from U.S. universities who will draw from Siemens’ ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young Asset ... celebrates the beginning of the latest charity campaign in their community enrichment program. ... Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ . ...
Breaking Medicine News(10 mins):